Clinical Trials Logo

Erectile Dysfunction clinical trials

View clinical trials related to Erectile Dysfunction.

Filter by:

NCT ID: NCT05466695 Not yet recruiting - Clinical trials for Erectile Dysfunction and Neutrophil Lymphocyte Ratio

Comparing The Effect of Tadalafil 5 mg/Day to Sildenafil 25 mg/Day on Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios in Erectile Dysfunction Patients; and Comparison of Clinical Response

Start date: August 1, 2022
Phase: Early Phase 1
Study type: Interventional

1- To evaluate the effect of using tadalafil 5mg/day or sildenafil 25mg/day in the treatment on these ratios and its clinical effect in erectile dysfunction patients.

NCT ID: NCT05462171 Completed - Clinical trials for Erectile Dysfunction

The Prevalence of Erectile Dysfunction (ED) and Premature Ejaculation (PE) in Poland

ED POLAND
Start date: July 1, 2022
Phase:
Study type: Observational

The first large population-based study to evaluate erectile dysfunction (ED) and premature ejaculation (PE) in Poland. The study objective is to assess the prevalence and bother of ED and PE in the representative group of male population of Poland.

NCT ID: NCT05451563 Recruiting - Clinical trials for Erectile Dysfunction

Double-S: a Wearable Device for Erectile Dysfunction

Start date: March 21, 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to use a minimally invasive erectile device for patients suffering from erectile dysfunction.

NCT ID: NCT05446493 Completed - Clinical trials for Erectile Dysfunction

Serum YKL-40 Level and Platelets Indices Among Patients With Diabetic Erectile Dysfunction

Start date: April 1, 2019
Phase: Phase 4
Study type: Interventional

The aim of this current study is to estimate serum level of YKL-40, serum total testosterone and platelets indices in diabetic patients with erectile dysfunction treated by daily tadalafil 5mg for 3 months.

NCT ID: NCT05439486 Active, not recruiting - Clinical trials for Erectile Dysfunction

New Treatment in Erectile Dysfunction Patients.

Start date: January 29, 2022
Phase: N/A
Study type: Interventional

Erectile dysfunction patients who are non responder to sildenafil will be treated with hyperbaric oxygen therapy with 100% concentration and at 2 ATM for 30 consecutive sessions each one 90 minutes and then will be reassessed.

NCT ID: NCT05388825 Completed - Clinical trials for Erectile Dysfunction

Pharmacodynamic Study of TPN171H Tablets in Patients With Mild to Moderate Erectile Dysfunction

Start date: August 1, 2022
Phase: Phase 2
Study type: Interventional

This study is a randomized, double-blind, placebo-controlled, two-cohort, three-cycle crossover (at least a 5-day cleaning period per cycle), and a multicenter clinical trial design.

NCT ID: NCT05385822 Recruiting - Clinical trials for Erectile Dysfunction

Pelvic Floor Muscle Training in the Treatment of Erectile Dysfunction

Start date: May 1, 2022
Phase: N/A
Study type: Interventional

Erectile dysfunction affects about 40% of all men above the age of 40 and the prevalence increases with increasing age. It is not possible to cure the condition as current forms of treatment are aimed solely at improving symptoms. Treatment options today include medications, injection therapy, and vacuum pumps, among others. However, pelvic floor muscle training is a natural, inexpensive, and non-invasive form of treatment that is used to a limited extent. Theoretically, a strengthening of the pelvic floor muscles can help increase the intracavernous pressure and thereby the hardness of the erection. Furthermore, tense pelvic floor muscles can help compress pelvic veins and reduce blood flow away from the penis which prolongs the erection. Finally, it is possible that pelvic floor muscle training can contribute to an increased blood supply to the pelvic floor and the penis which will have positive effects in relation to both the integrity of the penile tissue and the physiological erection mechanism itself. This study aims to investigate the effect of pelvic floor muscle training in men with erectile dysfunction. The study hypothesis is that pelvic floor training can provide a clinically significant improvement in the erection function at individual patient level

NCT ID: NCT05371951 Withdrawn - Clinical trials for Erectile Dysfunction

Effect of Erchonia Laser on Erectile Dysfunction

Start date: October 5, 2021
Phase: N/A
Study type: Interventional

This study is to see if applying low-level laser light can provide improvement in erectile dysfunction

NCT ID: NCT05366504 Not yet recruiting - Clinical trials for Erectile Dysfunction

LiST Plus PRP Injection Therapy vs LiST Monotherapy for ED Treatment

Start date: September 2022
Phase: Phase 2/Phase 3
Study type: Interventional

We designed a double blind randomized sham-controlled trial in order to investigate and compare the treatment efficacy of LiST plus PRP intracorporeal injection vs LiST plus placebo (normal saline intracorporeal injection) in men with moderate and mild to moderate vasculogenic ED, as measured by IIEF-EF.

NCT ID: NCT05363644 Withdrawn - Prostate Cancer Clinical Trials

BioDFence® G3 For Full Nerve-Sparing Robotic-Assisted Radical Prostatectomy

Start date: April 1, 2023
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess functional outcomes post operatively after the use of BioDFence® G3 during robotic radical prostatectomy.